Cargando…
Landscape of alterations in the checkpoint system in myelodysplastic syndrome and implications for prognosis
The emergence of novel immunotherapies for myelodysplastic syndrome (MDS) calls for a profound characterization of the "immunome" in the bone marrow (BM) and evaluation of prognostic impact of immunological changes. We performed a prospective study of 87 MDS patients who were referred to a...
Autores principales: | Moiseev, Ivan, Tcvetkov, Nikolai, Epifanovskaya, Olga, Babenko, Elena, Parfenenkova, Anna, Bakin, Evgenii, Yurovskaya, Ksenia, Morozova, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595516/ https://www.ncbi.nlm.nih.gov/pubmed/36282797 http://dx.doi.org/10.1371/journal.pone.0275399 |
Ejemplares similares
-
Immune checkpoints bone marrow expression as the predictor of clinical outcome in myelodysplastic syndrome
por: Tcvetkov, Nikolai, et al.
Publicado: (2020) -
High mutation burden in the checkpoint and micro-RNA processing genes in myelodysplastic syndrome
por: Moiseev, Ivan Sergeevich, et al.
Publicado: (2021) -
P738: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THERAPY-RELATED MYELODYSPLASTIC SYNDROME: A RETROSPECTIVE COHORT MATCHED STUDY
por: Kotselyabina, Polina, et al.
Publicado: (2023) -
Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome
por: Guo, Xinyu, et al.
Publicado: (2023) -
Immune checkpoint gene
VSIR
predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes
por: Yao, Kevin, et al.
Publicado: (2022)